Ann Herman

2.3k total citations
26 papers, 1.4k citations indexed

About

Ann Herman is a scholar working on Immunology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Ann Herman has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Ann Herman's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Diabetes and associated disorders (5 papers). Ann Herman is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Diabetes and associated disorders (5 papers). Ann Herman collaborates with scholars based in United States, Switzerland and Canada. Ann Herman's co-authors include Christophe Benoıst, Diane Mathis, Gordon J. Freeman, Zhibin Chen, Amit Bar‐Or, Cathy Chognot, Daniela Stokmaier, Edward Fox, Jonathan Calkwood and Derrick Robertson and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Ann Herman

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Herman United States	15	827	367	325	182	170	26	1.4k
Marion Salou France	17	1.2k 1.4×	132 0.4×	271 0.8×	246 1.4×	66 0.4×	30	1.6k
Sophie Hillion France	26	1.1k 1.4×	145 0.4×	184 0.6×	148 0.8×	173 1.0×	56	1.7k
Luca Castelli Italy	11	1.3k 1.5×	189 0.5×	127 0.4×	216 1.2×	98 0.6×	17	1.8k
Kristina M. Harris United States	22	680 0.8×	413 1.1×	199 0.6×	303 1.7×	479 2.8×	41	1.8k
Kim Waggie United States	10	865 1.0×	167 0.5×	102 0.3×	196 1.1×	165 1.0×	12	1.5k
L. Hashimoto United Kingdom	14	512 0.6×	831 2.3×	362 1.1×	139 0.8×	376 2.2×	21	1.6k
Jon D. Laman Netherlands	12	1.1k 1.3×	68 0.2×	356 1.1×	222 1.2×	83 0.5×	14	1.6k
Kylie E. Webster Australia	22	1.4k 1.7×	388 1.1×	59 0.2×	214 1.2×	141 0.8×	26	2.1k
Leigh A. Stephens United Kingdom	17	1.8k 2.2×	443 1.2×	139 0.4×	295 1.6×	274 1.6×	18	2.2k
Elise H. Tran Canada	7	1.5k 1.8×	124 0.3×	266 0.8×	414 2.3×	80 0.5×	8	1.9k

Countries citing papers authored by Ann Herman

Since Specialization

Citations

This map shows the geographic impact of Ann Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Herman more than expected).

Fields of papers citing papers by Ann Herman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Herman. The network helps show where Ann Herman may publish in the future.

Co-authorship network of co-authors of Ann Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Herman. A scholar is included among the top collaborators of Ann Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Herman. Ann Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Jessica, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.. (2025). Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosis. Journal of Clinical Investigation. 135(11). 2 indexed citations

Laurent, Sarah, Nicolas Strauli, Erica Eggers, et al.. (2023). Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial. Neurology Neuroimmunology & Neuroinflammation. 10(4). 8 indexed citations

Looney, Cary M., Nicolas Strauli, Matthew D. Cascino, et al.. (2023). Development of a novel, highly sensitive assay for quantification of minimal residual B cells in autoimmune disease and comparison to traditional methods across B-cell–depleting agents. Clinical Immunology. 248. 109265–109265. 6 indexed citations

Bar‐Or, Amit, Christopher Harp, Corrado Bernasconi, et al.. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. EBioMedicine. 93. 104662–104662. 46 indexed citations

Herman, Ann. (2021). YOU BELONG WITH ME: RECORDING ARTISTS’ FIGHT FOR OWNERSHIP OF THEIR MASTERS. eYLS (Yale Law School). 18(2). 239.

Stefanich, Eric, Julie Rae, Siddharth Sukumaran, et al.. (2018). Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochemical Pharmacology. 152. 224–235. 41 indexed citations

Rothenberg, Michael E., Yehong Wang, Annemarie Lekkerkerker, et al.. (2018). Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury. Clinical Pharmacology & Therapeutics. 105(1). 177–189. 53 indexed citations

Lee, Donna W., Rama Pai, Julie Rae, et al.. (2018). Nonclinical safety assessment of a human interleukin‐22FC IG fusion protein demonstrates in vitro to in vivo and cross‐species translatability. Pharmacology Research & Perspectives. 6(6). e00434–e00434. 13 indexed citations

Anania, Veronica G., Kebing Yu, Francesco Pingitore, et al.. (2018). Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis. Journal of Proteome Research. 18(3). 1264–1277. 18 indexed citations

10.

Lekkerkerker, Annemarie, Brandon Harder, Prasad S. Kulkarni, et al.. (2017). P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial. Journal of Crohn s and Colitis. 11(suppl_1). S289–S289. 3 indexed citations

11.

Lau, Janet, Qiang Zhou, Susan Sutton, et al.. (2014). Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice. PLoS ONE. 9(1). e84900–e84900. 9 indexed citations

12.

Lau, Janet, Deborah Knee, Christophe Filippi, et al.. (2013). IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes. PLoS ONE. 8(10). e78483–e78483. 14 indexed citations

13.

Herman, Ann, David Musselman, Audi Setiadi, et al.. (2013). THU0130 Distinct Biomarkers Enrich for Clinical Response to Tocilizumab (TCZ) and Adalimumab (ADA) in Adacta: A Head-to-Head Monotherapy Study in Patients (PTS) with Methotrexate (MTX)-IR Rheumatoid Arthritis (RA). Annals of the Rheumatic Diseases. 72. A206–A206. 2 indexed citations

14.

Mak, Puiying A., George França dos Santos, Kelly‐Anne Masterman, et al.. (2011). Development of an Automated, High-Throughput Bactericidal Assay That Measures Cellular Respiration as a Survival Readout for Neisseria meningitidis. Clinical and Vaccine Immunology. 18(8). 1252–1260. 26 indexed citations

15.

Huang, Yina H., Rina Barouch‐Bentov, Ann Herman, John R. Walker, & Karsten Sauer. (2007). Integrating Traditional and Postgenomic Approaches to Investigate Lymphocyte Development and Function. Advances in experimental medicine and biology. 584. 245–276. 4 indexed citations

16.

Melamed, Rachel, Richard Park, Catherine Laplace, et al.. (2006). Gene expression microarrays: glimpses of the immunological genome. Nature Immunology. 7(7). 686–691. 59 indexed citations

17.

Chen, Zhibin, et al.. (2005). Where CD4 + CD25 + T reg cells impinge on autoimmune diabetes. The Journal of Experimental Medicine. 202(10). 1387–1397. 231 indexed citations

18.

Herman, Ann, Gordon J. Freeman, Diane Mathis, & Christophe Benoıst. (2004). CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion. The Journal of Experimental Medicine. 199(11). 1479–1489. 368 indexed citations

19.

Herman, Ann, Roland Tisch, Salil D. Patel, et al.. (1999). Determination of Glutamic Acid Decarboxylase 65 Peptides Presented by the Type I Diabetes-Associated HLA-DQ8 Class II Molecule Identifies an Immunogenic Peptide Motif. The Journal of Immunology. 163(11). 6275–6282. 46 indexed citations

20.

Davila, Joanne, et al.. (1995). Comparison of the sedative effectiveness of two pharmacological regimens.. PubMed. 61(4). 276–81. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact